The Gram-Negative Bacterial Pneumonia EpiCast Report and EpiCast Model provide an overview of the risk factors and epidemiological trends for pneumonia, with a focus on gram-negative bacteria, in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of incident cases of community-acquired pneumonia (CAP) segmented by sex and age (in five-year increments beginning at 0 years and ending at =85 years), incident cases of hospital-acquired pneumonia (HAP), and incident cases of ventilator-associated pneumonia (VAP). Incident HAP cases are further segmented by causative pathogens (Acinetobacter, Escherichia coli, Klebsiella, and Pseudomonas) and antibiotic resistance in these markets.

1. EpiCast Report: Gram-Negative Bacterial Pneumonia – Epidemiology
Forecast to 2022
by
GlobalData
Browse more reports on
Infectious Diseases Therapeutics
Market @ http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/therapeutics/infectious-diseases-therapeutics .
© RnRMarketResearch.com ; sales@rnrmarketresearch.com ;
+1 888 391 5441

2. EpiCast Report: Gram-Negative Bacterial
Pneumonia – Epidemiology Forecast to 2022
Pneumonia is one of the most common infectious diseases and is caused by infectious agents such as
bacteria, viruses, and fungi. Pneumonia is an acute respiratory infection that inflames the alveoli (air
sacs) in the lungs through fluid or pus. The inflamed alveoli causes limited oxygen intake in the lungs
and breathing difficulties for individuals, manifesting in symptoms of coughing, chest pain, and fever.
Pneumonia is a major public health concern in both developed and developing countries.
Chronic diseases such as asthma, chronic obstructive pulmonary disease, and heart disease increase
the risk of developing pneumonia. Elderly patients (65 years and older) have twice the incidence of
hospital-acquired pneumonia compared with the adult population. Additionally, tobacco smoking has
been identified as a cause of pneumonia.
In 2012, the 6MM (US, France, Germany, Italy, Spain, UK) had 4,184,449 incident cases of CAP, with
82% of that occurring in the US. By 2022, GlobalData epidemiologists forecast there will be 4,670,664
incident cases of CAP in the 6MM. In Japan, there were 40,043 cases of CAP and HAP with an annual
growth rate (AGR) of 3.78%.
Complete report available @ http://www.rnrmarketresearch.com/ultrabooks-market-to-2016financial-and-technological-support-from-intel-corporation-coupled-with-demand-from-businessusers-segment-will-drive-growth-market-report.html .
© RnRMarketResearch.com ; sales@rnrmarketresearch.com ;
+1 888 391 5441

3. EpiCast Report: Gram-Negative Bacterial
Pneumonia – Epidemiology Forecast to 2022
Scope
The Gram-Negative Bacterial Pneumonia EpiCast Report and EpiCast Model provide an overview of the risk factors and
epidemiological trends for pneumonia, with a focus on gram-negative bacteria, in the seven major markets (7MM) (US,
France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of incident cases of
community-acquired pneumonia (CAP) segmented by sex and age (in five-year increments beginning at 0 years and
ending at =85 years), incident cases of hospital-acquired pneumonia (HAP), and incident cases of ventilator-associated
pneumonia (VAP). Incident HAP cases are further segmented by causative pathogens (Acinetobacter, Escherichia coli,
Klebsiella, and Pseudomonas) and antibiotic resistance in these markets.
The gram-negative bacterial pneumonia epidemiology report and model were written and developed by Masters- and
PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in
the 7MM.
The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and
consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over
a 10-year forecast period using reputable sources.
Request a sample copy @ http://www.rnrmarketresearch.com/contacts/requestsample?rname=120451 .
© RnRMarketResearch.com ; sales@rnrmarketresearch.com ;
+1 888 391 5441

4. EpiCast Report: Gram-Negative Bacterial
Pneumonia – Epidemiology Forecast to 2022
For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com /
+18883915441
RnR Market Research
RnRMarketResearch.com, an online repository of market research reports, offers in-depth
analysis of over 5000 market segments. RnR Market Research library has syndicated reports by
leading market research publishers across the globe.
© RnRMarketResearch.com ; sales@rnrmarketresearch.com ;
+1 888 391 5441